mycobacteria

简明释义

英[ˌmaɪkəʊbækˈtɪərɪə]美[miːkoʊbækˈtɪrɪə]

n. [微] 分枝杆菌；分枝细菌

英英释义

单词用法

同义词

反义词

例句

1.Objective to explore the in-vivo culturing technique of mycobacteria from special hand infections in laboratory, and to provide the direct evidence for clinical diagnosis.

目的探讨沿海地区手部非结核分枝杆菌感染的体外培养技术和要领，为临床确诊，治疗提供直接证据。

2.Mycobacteria, including Mycobacterium tuberculosis, and spore-forming bacteria, including Clostridium difficile, can also survive for months on surfaces.

分支杆菌，包括结核分支杆菌，和孢子形成俊，包括艰难梭菌，也能存活数月时间。

3.In order to find the mycobacteria in a tissue section, a stain for acid fast bacilli is done (AFB stain).

为了在组织切片上发现分支杆菌，进行抗酸染色(afb染色)。

4.Objective: By analyzing the cause fester lymph node mycobacteria specimens, pathological first-line therapy in clinical bacteriology provide reliable scientific basis.

目的：分析由分支杆菌引起的淋巴结化脓性病变标本的细菌学，为临床第一线治疗提供可靠的科学依据。

5.The parents have already both developed an immune response to mycobacteria.

父母已经产生了针对分枝杆菌的免疫应答。

6.Outbreaks of iatrogenic infection by nontuberculous mycobacteria(NTM) trends to rise.

非结核分枝菌（NTM）引起医院感染的爆发流行呈上升趋势。

7.The presence of mycobacteria in water sources can pose a health risk to the community.

水源中存在的分枝杆菌可能对社区健康构成威胁。

8.The laboratory is conducting research on mycobacteria to develop new antibiotics.

实验室正在对分枝杆菌进行研究，以开发新型抗生素。

9.Infections caused by mycobacteria can be difficult to treat due to their resistance to many drugs.

由分枝杆菌引起的感染由于对许多药物的耐药性而难以治疗。

10.Vaccination against tuberculosis helps prevent infections from mycobacteria.

接种结核病疫苗有助于预防来自分枝杆菌的感染。

11.Doctors often test for mycobacteria in patients with persistent cough and fever.

医生通常会在有持续咳嗽和发热的患者中检测分枝杆菌。

作文

Mycobacteria are a genus of bacteria known for their unique characteristics and significant impact on human health. These microorganisms are rod-shaped, aerobic, and have a waxy cell wall that makes them resistant to many common antibiotics. One of the most well-known species of mycobacteria (分枝杆菌) is Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), a disease that has plagued humanity for centuries. The study of mycobacteria (分枝杆菌) is crucial for understanding how these bacteria survive in hostile environments and evade the immune system. The waxy cell wall of mycobacteria (分枝杆菌) contains mycolic acids, which not only provide structural integrity but also contribute to the bacteria's virulence. This unique feature allows mycobacteria (分枝杆菌) to resist desiccation and chemical damage, making them more resilient than many other bacterial species. In addition to tuberculosis, other notable species include Mycobacterium leprae, which causes leprosy, and Mycobacterium avium, which can cause opportunistic infections in immunocompromised individuals. Understanding the biology of mycobacteria (分枝杆菌) is essential for developing effective treatments and preventive measures against diseases they cause. For instance, the standard treatment for TB involves a combination of antibiotics taken over several months. However, the emergence of multidrug-resistant strains of mycobacteria (分枝杆菌) poses a significant challenge in public health. Research continues to focus on finding new drugs and therapies to combat these resistant strains, as well as vaccines to prevent infection. In addition to their medical significance, mycobacteria (分枝杆菌) also play an important role in environmental ecosystems. Some species are involved in the decomposition of organic matter and contribute to nutrient cycling in soil and aquatic environments. This ecological role highlights the importance of mycobacteria (分枝杆菌) beyond their pathogenic potential. The study of mycobacteria (分枝杆菌) is further complicated by their slow growth rates and the difficulty in culturing them in laboratory settings. Traditional methods of identifying and studying bacteria may not be effective for mycobacteria (分枝杆菌), necessitating the use of molecular techniques such as polymerase chain reaction (PCR) and sequencing. These advanced methods have greatly improved our understanding of mycobacteria (分枝杆菌) and their genetic diversity, aiding in the development of targeted treatments. In conclusion, mycobacteria (分枝杆菌) represent a fascinating and complex group of bacteria with significant implications for human health and the environment. Their unique characteristics make them both a challenge and a subject of interest for researchers. As we continue to learn more about these organisms, it is vital to address the public health challenges they pose while also appreciating their ecological contributions. The ongoing research into mycobacteria (分枝杆菌) will undoubtedly lead to new insights and innovations in both medicine and environmental science.

分枝杆菌是一个细菌属，以其独特的特性和对人类健康的重要影响而闻名。这些微生物呈杆状，需氧，并且具有蜡质细胞壁，使其对许多常见抗生素具有抗药性。最著名的mycobacteria（分枝杆菌）物种之一是结核分枝杆菌，它是结核病的致病因子，这种疾病已经困扰人类几个世纪。研究mycobacteria（分枝杆菌）对于理解这些细菌如何在恶劣环境中生存以及如何逃避免疫系统至关重要。mycobacteria（分枝杆菌）的蜡质细胞壁含有分枝酸，这不仅提供了结构完整性，还增强了细菌的致病性。这一独特特征使得mycobacteria（分枝杆菌）能够抵抗干燥和化学损伤，使其比许多其他细菌物种更具韧性。除了结核病，其他显著的物种还包括麻风分枝杆菌，它引起麻风，以及鸟分枝杆菌，它可以在免疫功能低下的个体中引起机会性感染。了解mycobacteria（分枝杆菌）的生物学对于开发有效的治疗和预防措施至关重要。例如，结核病的标准治疗涉及多种抗生素的组合，持续几个月。然而，多药耐药性mycobacteria（分枝杆菌）株的出现对公共卫生构成了重大挑战。研究仍然集中在寻找新药物和疗法来对抗这些耐药株，以及预防感染的疫苗。除了医学意义外，mycobacteria（分枝杆菌）在环境生态系统中也发挥着重要作用。一些物种参与有机物的分解，并促进土壤和水域环境中的营养循环。这一生态角色突显了mycobacteria（分枝杆菌）在其致病潜力之外的重要性。对mycobacteria（分枝杆菌）的研究进一步复杂化，因为它们的生长速度缓慢，且在实验室环境中培养它们很困难。传统的细菌识别和研究方法可能对mycobacteria（分枝杆菌）无效，因此需要使用分子技术，如聚合酶链反应（PCR）和测序。这些先进的方法极大地改善了我们对mycobacteria（分枝杆菌）及其遗传多样性的理解，帮助开发针对性的治疗。总之，mycobacteria（分枝杆菌）代表了一组迷人且复杂的细菌，对人类健康和环境具有重要意义。它们的独特特性使它们既是挑战，也是研究人员关注的对象。随着我们继续了解这些生物，解决它们带来的公共卫生挑战，同时欣赏它们的生态贡献至关重要。对mycobacteria（分枝杆菌）的持续研究无疑将导致医学和环境科学的新见解和创新。